1 Day
Source:
وكالة الأنباء القطرية
Sodr for Medicine Offers Pediatric Neuroblastoma Treatments
The Pediatric Hematology and Oncology Team and Stem Cell Transplantation at Sidra Medicine successfully treated the first child in Qatar diagnosed with neuroblastoma at birth, using two monoclonal antibody therapies targeting GD2, specifically designed for high-risk tumors. Neuroblastoma is a type of cancer that develops in nerve tissue and typically affects infants and young children under five years old. The new treatment requires the collaboration of multidisciplinary teams and follows stem cell transplantation, marking a significant advancement in treatment options for children with this cancer in Qatar.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)